# A Study to Evaluate the Efficacy and Safety of UI022/UI023

Study · id `cardio:ct-nct07600385` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07600385](<https://clinicaltrials.gov/study/NCT07600385>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT07600385

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 260 participants.

## Technical summary

Registry record NCT07600385. Randomized; double masking; primary purpose treatment. Start 2019-03-12 (actual); primary completion 2022-05-03 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 260 participants (enrolled count; ClinicalTrials.gov record NCT07600385, source copy `cardio:ctgov-nct07600385-2026-05-20`, retrieved 2026-10-31)
- Started: 2019-03-12 (actual) (ClinicalTrials.gov record NCT07600385, source copy `cardio:ctgov-nct07600385-2026-05-20`, retrieved 2026-10-31)
- Primary completion: 2022-05-03 (actual) (ClinicalTrials.gov record NCT07600385, source copy `cardio:ctgov-nct07600385-2026-05-20`, retrieved 2026-10-31)
- Completion: 2022-05-03 (actual) (ClinicalTrials.gov record NCT07600385, source copy `cardio:ctgov-nct07600385-2026-05-20`, retrieved 2026-10-31)
- Countries: South Korea (ClinicalTrials.gov record NCT07600385, source copy `cardio:ctgov-nct07600385-2026-05-20`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07600385-2026-05-20`, retrieved 2026-10-31)

## The registry's words

- Brief title: A Study to Evaluate the Efficacy and Safety of UI022/UI023
- Condition: Peripheral Arterial Disease
- Intervention (Drug): UI022 or UI023 and co-administration of matching placebo
- Intervention (Drug): UIC201604 or UIC201801 and co-administration of matching placebo
- Lead sponsor: Korea United Pharm. Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)

## Provenance

Content hash: 5fd5f08c3dafd217239fae062faaadbd35a8c48871e4f6583def0c313b5ae0c2
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
